Clinical trial · Interventional
CINtec PLUS Triage in HPV Primary Screening
CINtec PLUS Triage of HPV Positive Women in HPV Primary Screening
NCT03721484CI-TRIAL-00035475unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prospective study which will recruit participants when they attend for a routine cervical screening. The study will evaluate the use of CINtec PLUS for triage of human papillomavirus (HPV) positive participants in HPV primary screening.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CINtec PLUS | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Risk of high-grade disease
- timeFrame
- 3 years
- description
- CIN2+ diagnosed on biopsy obtained at colposcopy.
- measure
- Risk of low-grade disease
- timeFrame
- 3 years
- description
- \<CIN2 as determined by colposcopy assessment/biopsy or cytology ≤Mild/HPV negative.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 25 Years
- Maximum age
- 64 Years
Show eligibility criteria text
Inclusion Criteria: * Consenting women aged 25y-64y attending for cervical screening Exclusion Criteria: * Women aged \<25y and \>64y
References
Publications (0)
Data not yet available
No reference posted for this study.